Jacobs Levy Equity Management Portfolio holdings
Jacobs Levy Equity Management manages U.S. stock portfolios, and its owners Bruce Jacobs and Ken Levy pioneered a research method called disentangling. The firm was founded in 1986, and Jacobs and Levy spent more than three years studying market inefficiencies in U.S. stocks before taking on client money in 1990. Disentangling examines many factors that move stock prices at once, to isolate the separate effect of each, and the firm blends it with behavioral finance theory and human judgment. It runs long-only and long/short portfolios across large and small companies, including versions that hold about 130% or 150% of capital in long positions and 30% or 50% in short ones. Its clients are institutions such as pension plans, endowments, foundations and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$325M |
| 2 |
CrowdStrike
CRWD
|
+$225M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$186M |
| 4 |
Sandisk
SNDK
|
+$155M |
| 5 |
Sysco
SYY
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$418M |
| 2 |
ServiceNow
NOW
|
+$262M |
| 3 |
Apple
AAPL
|
+$260M |
| 4 |
Masco
MAS
|
+$163M |
| 5 |
Roku
ROKU
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.14% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.2% |
| 5 | Healthcare | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
751
National Health Investors
NHI
$3.09B
| $774K | ﹤0.01% |
+10,150
| New | +$777K |
2026 Q2
0 quarters
|
|
752
Griffon
GFF
$4.76B
| $770K | ﹤0.01% |
7,890
-464
| -6% | -$40.5K |
2025 Q1
5 quarters
|
|
753
Orion Group Holdings
ORN
$308M
| $767K | ﹤0.01% |
45,627
-217,353
| -83% | -$3M |
2025 Q1
5 quarters
|
|
754
Lifetime Brands
LCUT
$179M
| $767K | ﹤0.01% |
+89,915
| New | +$695K |
2026 Q2
0 quarters
|
|
755
UroGen Pharma
URGN
$1.28B
| $762K | ﹤0.01% |
20,696
-11,813
| -36% | -$320K |
2025 Q3
3 quarters
|
|
756
Eagle Bancorp Montana
EBMT
$161M
| $760K | ﹤0.01% |
+31,768
| New | +$713K |
2026 Q2
0 quarters
|
|
757
Par Pacific Holdings
PARR
$3.66B
| $754K | ﹤0.01% |
13,449
| – | – |
2017 Q4
34 quarters
|
|
758
GrafTech
EAF
$261M
| $754K | ﹤0.01% |
+127,526
| New | +$1.08M |
2026 Q2
0 quarters
|
|
759
iRadimed
IRMD
$1.09B
| $752K | ﹤0.01% |
7,872
-812
| -9% | -$74K |
2023 Q2
12 quarters
|
|
760
Origin Bancorp
OBK
$1.67B
| $749K | ﹤0.01% |
14,651
-1,062
| -7% | -$50K |
2023 Q4
10 quarters
|
|
761
Sanara MedTech
SMTI
$297M
| $746K | ﹤0.01% |
+31,644
| New | +$654K |
2026 Q2
0 quarters
|
|
762
Mastercard
MA
$576B
| $745K | ﹤0.01% |
1,451
-91,013
| -98% | -$45.4M |
2013 Q2
52 quarters
|
|
763
Sportsman's Warehouse
SPWH
$46.2M
| $742K | ﹤0.01% |
+557,788
| New | +$763K |
2026 Q2
0 quarters
|
|
764
Arista Networks
ANET
$249B
| $740K | ﹤0.01% |
4,357
-302,668
| -99% | -$47.5M |
2019 Q1
29 quarters
|
|
765
Tonix Pharmaceuticals
TNXP
$58.5M
| $739K | ﹤0.01% |
+57,943
| New | +$748K |
2026 Q2
0 quarters
|
|
766
nLIGHT
LASR
$2.4B
| $739K | ﹤0.01% |
10,619
-136,134
| -93% | -$9.5M |
2026 Q1
1 quarter
|
|
767
XPO
XPO
$22.5B
| $738K | ﹤0.01% |
+3,595
| New | +$761K |
2026 Q2
0 quarters
|
|
768
Angel Oak Mortgage REIT
AOMR
$138M
| $736K | ﹤0.01% |
81,107
-9,634
| -11% | -$82.9K |
2024 Q3
7 quarters
|
|
769
Pliant Therapeutics
PLRX
$43.2M
| $733K | ﹤0.01% |
643,120
-75,423
| -10% | -$91.8K |
2025 Q3
3 quarters
|
|
770
Atrium Therapeutics
RNA
$162M
| $726K | ﹤0.01% |
+53,992
| New | +$705K |
2026 Q2
0 quarters
|
|
771
Caribou Biosciences
CRBU
$39.1M
| $723K | ﹤0.01% |
410,979
+52,038
| +14% | +$103K |
2024 Q4
6 quarters
|
|
772
Kaltura
KLTR
$211M
| $717K | ﹤0.01% |
551,235
+408,321
| +286% | +$554K |
2022 Q1
17 quarters
|
|
773
Voya Financial
VOYA
$9.11B
| $713K | ﹤0.01% |
7,875
+3,222
| +69% | +$262K |
2024 Q2
8 quarters
|
|
774
Zillow
ZG
$6.79B
| $710K | ﹤0.01% |
22,642
-18,052
| -44% | -$697K |
2026 Q1
1 quarter
|
|
775
AMC Global Media
AMCX
$391M
| $698K | ﹤0.01% |
69,953
-27,705
| -28% | -$246K |
2024 Q3
7 quarters
|
|
Similar funds
Jacobs Levy Equity Management's Q2 2026 Portfolio in Review
As of Q2 2026, Jacobs Levy Equity Management held 1,111 positions worth $27.8B, up 17% from $23.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jacobs Levy Equity Management's Q2 2026 filing shows 158 new, 319 increased, 438 reduced and 177 closed positions. Its largest new stake was Sysco: 1,938,184 shares worth $162M. The largest sale was Qualcomm, an estimated $418M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2026 buy was Sysco: 1,938,184 shares worth $162M.
- Jacobs Levy Equity Management added most to KLA in Q2 2026, an estimated $325M increase.
- Jacobs Levy Equity Management's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $418M.
- Jacobs Levy Equity Management fully exited Roku in Q2 2026, selling an estimated $139M.
- Jacobs Levy Equity Management's ten largest holdings make up 28% of its $27.8B portfolio in Q2 2026.
- Jacobs Levy Equity Management opened 158 new positions and closed 177 in Q2 2026.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $27.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.